Actinium Pharmaceuticals, Inc.(NYSE Amex Equities : ATNM)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -5.38% | 430.14 | 0.0% | $5769.95m | |
| BNTX | BioNTech SE | -5.53% | 333.48 | 0.0% | $994.80m | |
| NVAX | Novavax, Inc. | -3.55% | 248.16 | 79.4% | $950.95m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -0.46% | 8.65 | 0.7% | $604.67m | |
| AMGN | Amgen, Inc. | -0.67% | 213.61 | 1.4% | $550.92m | |
| GILD | Gilead Sciences, Inc. | -0.70% | 71.19 | 1.0% | $455.28m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.18% | 638.90 | 2.7% | $418.56m | |
| TECH | Bio-Techne Corp. | 0.37% | 538.88 | 4.5% | $356.85m | |
| ILMN | Illumina, Inc. | -0.09% | 432.82 | 3.5% | $356.73m | |
| BIIB | Biogen, Inc. | -0.51% | 291.71 | 1.7% | $309.48m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.80% | 183.61 | 1.9% | $245.25m | |
| ISEE | IVERIC bio, Inc. | 0.86% | 16.37 | 0.0% | $193.25m | |
| DVAX | Dynavax Technologies Corp. | 1.17% | 19.83 | 5.7% | $156.65m | |
| LIFE | aTyr Pharma, Inc. | -17.87% | 10.25 | 2.1% | $156.36m | |
| BGNE | BeiGene Ltd. | -1.53% | 379.52 | 1.3% | $144.32m |
Company Profile
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates (ARCs), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company was founded in 2002 and is headquartered in New York, NY.